Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1-antibody-drug conjugate.

ABSTRACT:

SUBMITTER: Tang T 

PROVIDER: S-EPMC9701621 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature